Last reviewed · How we verify
R-albuterol, S-albuterol
At a glance
| Generic name | R-albuterol, S-albuterol |
|---|---|
| Sponsor | Hamilton Health Sciences Corporation |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Continuous Levalbuterol for Treatment of Status Asthmaticus in Children (PHASE4)
- Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- R-albuterol, S-albuterol CI brief — competitive landscape report
- R-albuterol, S-albuterol updates RSS · CI watch RSS
- Hamilton Health Sciences Corporation portfolio CI